A meta-analysis of the association between adherence to drug therapy and mortality
By S. Simpson, D. Eurich, S. Majumdar, R. Padwal, R. Tsuyuki, J. Varney, Jeffrey A. Johnson. British medical journal, 2006
1,389 citations recorded by the source corpus.
Subfields: Family Practice, Psychiatry and Mental health, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/54606639ddb694783b6c8c504dc1eeabd7a373b3
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Family Practice
In Psychiatry and Mental health
In Public Health, Environmental and Occupational Health
Citations in the corpus
- Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. (2007, methodology): “However, their projected survival impact in the real world is less known, in part because of variations in drug adherence.(3,4) Although it is known that adherence to evidence-based pharmacotherapy predicts better survival,(5-11) no population outcome study has attempted to differentiate whether the”
- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. (2017, background): “Low treatment adherence is an important barrier to achieving optimal treatment targets and is associated with worse outcomes.(317)”
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice (2017, neutral): “Adherence to medication in individuals at high risk and in pa-tients with CVD is low, resulting in worse outcomes and higher health care costs [487].”
- Guidelines on cardiovascular disease prevention in clinical practice: the European perspective (2005, neutral): “3034 3035 Adherence to medication in individuals at high risk and in patients with CVD is low, resulting 3036 in worse outcomes and higher healthcare costs.(490) One month after AMI, 25–30% of patients 3037 stop at least one drug, with a progressive decline in adherence over time.”
- Understanding Patients’ Adherence-Related Beliefs about Medicines Prescribed for Long-Term Conditions: A Meta-Analytic Review of the Necessity-Concerns Framework (2013, background): “both for individual patients, in terms of lost opportunities for health gain with increased morbidity and mortality [3], and for the health care system, in terms of wasted resources, increased use of services and hospital admissions [4].”
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice (2016, background): “Adherence to medication in individuals at high risk and in patients with CVD is low, resulting in worse outcomes and higher health care costs.(487) One month after AMI, 25–30% of patients stop at least one drug, with a progressive decline in adherence over time.”
- Self-report measures of medication adherence behavior: recommendations on optimal use (2015, background): “Acrossmany chronicmedical conditions, adherence has been associated with positive clinical outcomes including improved disease control, reduced symptoms, and decreased complications, hospitalization, and mortality [13–20].”